Plasma Cholesterol-Lowering Activity of Lard Functionalized with Mushroom Extracts Is Independent of Niemann–Pick C1-like 1 Protein and ABC Sterol Transporter Gene Expression in Hypercholesterolemic Mice

• Published in: Journal of agricultural and food chemistry 2016-03, Vol.64 (8), p.1686-1694
• Main Authors: Caz, Víctor, Gil-Ramírez, Alicia, Santamaría, Mónica, Tabernero, María, Soler-Rivas, Cristina, Martín-Hernández, Roberto, Marín, Francisco R, Reglero, Guillermo, Largo, Carlota
• Format: Article
• Language: English
• Subjects: Agaricales - chemistry; Animals; Anticholesteremic Agents - administration & dosage; ATP Binding Cassette Transporter, Sub-Family G, Member 5; ATP-Binding Cassette Transporters - genetics; ATP-Binding Cassette Transporters - metabolism; beta-Glucans - administration & dosage; Cholesterol - blood; Dietary Fats - administration & dosage; Gene Expression - drug effects; Humans; Hypercholesterolemia - blood; Hypercholesterolemia - drug therapy; Hypercholesterolemia - genetics; Hypercholesterolemia - metabolism; Lipoproteins - genetics; Lipoproteins - metabolism; Male; Membrane Transport Proteins - genetics; Membrane Transport Proteins - metabolism; Mice
• ISSN: 0021-8561; 1520-5118
• DOI: 10.1021/acs.jafc.5b05490

Interest in food matrices supplemented with mushrooms as hypocholesterolemic functional foods is increasing. This study was to (i) investigate the hypocholesterolemic activity of lard functionalized with mushroom extracts (LF) including fungal β-glucans, water-soluble polysaccharides, or ergosterol and (ii) examine the LF influence on transcriptional mechanisms involved in cholesterol metabolism. mRNA levels of 17 cholesterol-related genes were evaluated in jejunum, cecum, and liver of high cholesterol-fed mice. The four tested LFs decreased plasma cholesterol by 22–42%, HDLc by 18–40%, and LDLc by 27–51%, and two of them increased mRNA levels of jejunal Npc1l1 and Abcg5 and hepatic Npc1l1. mRNA levels of other cholesterol-related genes were unchanged. These findings suggest that LF may have potential as a dietary supplement for counteracting diet-induced hypercholesterolemia and could be a source for the development of novel cholesterol-lowering functional foods. However, the cholesterol-lowering effect was unrelated to transcriptional changes, suggesting that post-transcriptional mechanisms could be involved.